cyc 202 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 3 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (6-cyano-7-nitroquinoxaline-2,3-dione) | Trials (6-cyano-7-nitroquinoxaline-2,3-dione) | Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 2,698 | 1 | 353 |
| Protein | Taxonomy | cyc 202 (IC50) | 6-cyano-7-nitroquinoxaline-2,3-dione (IC50) |
|---|---|---|---|
| Glutamate receptor 1 | Homo sapiens (human) | 1.02 | |
| Glutamate receptor 2 | Homo sapiens (human) | 1.02 | |
| Glutamate receptor 3 | Homo sapiens (human) | 1.02 | |
| Glutamate receptor 4 | Homo sapiens (human) | 1.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Ari, Y; Ivanov, A; Tyzio, R; Zilberter, Y | 1 |
| Kim, SH; Ryan, TA | 1 |
| Burden, JJ; Gitler, D; Kahn, J; Lavy, Y; Marra, V; Orenbuch, A; Shalev, L; Sinai, I; Staras, K | 1 |
3 other study(ies) available for cyc 202 and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
(R)-roscovitine, a cyclin-dependent kinase inhibitor, enhances tonic GABA inhibition in rat hippocampus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Calcium; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Agents; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hippocampus; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Membrane Potentials; Neural Inhibition; Neurons; Patch-Clamp Techniques; Protein Kinase Inhibitors; Purines; Rats; Roscovitine | 2008 |
CDK5 serves as a major control point in neurotransmitter release.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Cyclin-Dependent Kinase 5; Electric Stimulation; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; In Vitro Techniques; Munc18 Proteins; Neurons; Neurotransmitter Agents; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Roscovitine; Sodium Channel Blockers; Synapses; Tetrodotoxin; Transfection; Valine; Vesicle-Associated Membrane Protein 2 | 2010 |
Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Cells, Cultured; Excitatory Amino Acid Antagonists; Fluorescence Recovery After Photobleaching; Gene Expression Regulation; Hippocampus; Humans; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Nerve Tissue Proteins; Neurons; Presynaptic Terminals; Protein Kinase Inhibitors; Protein Transport; Purines; Pyridinium Compounds; Quaternary Ammonium Compounds; Roscovitine; Statistics, Nonparametric; Synapsins; Synaptic Vesicles; Time Factors; Transfection; Valine; Vesicle-Associated Membrane Protein 2 | 2012 |